Expression of the ATP-binding cassette membrane transporter, ABCG2, in human and rodent brain microvessel endothelial and glial cell culture systems

Pharmaceutical Research

Volumn 24, Issue 7, 2007, Pages 1262-1274

  Lee, Gloria ^a   Babakhanian, Karlo ^a   Ramaswamy, Manisha ^a   Prat, Alexandre ^b   Wosik, Karolina ^b   Bendayan, Reina ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

ABCG2 (BCRP); Brain; Glial cells; Microvessel endothelial cells; Mitoxantrone; Transport

Indexed keywords

ABC TRANSPORTER; BREAST CANCER RESISTANCE PROTEIN; MESSENGER RNA; MITOXANTRONE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BXP 21; PHEOPHORBIDE; PROTEIN INHIBITOR; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY DETECTION; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; CANCER CELL CULTURE; CELL MEMBRANE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME SUBSTRATE; GENE LOCATION; GLIA CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE MICROSCOPY; INTRACELLULAR SPACE; MICROVASCULATURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RODENT; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; ATP-BINDING CASSETTE TRANSPORTERS; BLOTTING, WESTERN; BRAIN; BREAST NEOPLASMS; CELL LINE, TUMOR; CHLOROPHYLL; ENDOTHELIAL CELLS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; INDOLES; MICROCIRCULATION; MICROGLIA; MITOXANTRONE; NEOPLASM PROTEINS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TRANSFECTION; TRITIUM;

EID: 34249879813     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-007-9244-1     Document Type: Article

References (39)

1. L. A. Doyle, W. Yang, L. V. Abruzzo, T. Krogmann, Y. Gao, A. K. Rishi, and D. D. Ross. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 95:15665-15670 (1998).
2. J. D. Allen, R. F. Brinkhuis, J. Wijnholds, and A. H. Schinkel. The mouse Bcrp1/Mxr/Abcp gene: amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin. Cancer Res. 59:4237-4241 (1999).
3. T. Eisenblatter, S. Huwel, and H. J. Galla. Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood-brain barrier. Brain Res. 971:221-231 (2003).
4. S. Hori, S. Ohtsuki, M. Tachikawa, N. Kimura, T. Kondo, M. Watanabe, E. Nakashima, and T. Terasaki. Functional expression of rat ABCG2 on the luminal side of brain capillaries and its enhancement by astrocyte-derived soluble factor(s). J. Neurochem. 90:526-536 (2004).
5. K. E. Berge, H. Tian, G. A. Graf, L. Yu, N. V. Grishin, J. Schultz, P. Kwiterovich, B. Shan, R. Barnes, and H. H. Hobbs. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290:1771-1775 (2000).
6. J. Xu, Y. Liu, Y. Yang, S. Bates, and J. T. Zhang. Characterization of oligomeric human half-ABC transporter ATP binding cassette G2. J. Biol. Chem. 279:19781-19789 (2004).
7. F. Staud and P. Pavek. Breast cancer resistance protein (BCRP/ABCG2). Int. J. Biochem. Cell Biol. 37:720-725 (2005).
8. M. Maliepaard, G. L. Scheffer, I. F. Faneyte, M. A. van Gastelen, A. C. L. M. Pijnenborg, A. H. Schinkel, M. J. Van de Vijver, R. J. Scheper, and J. H. M. Schellens. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res. 61:3458-3464 (2001).
9. H. C. Cooray, C. G. Blackmore, L. Maskell, and M. A. Barrand. Localisation of breast cancer resistance protein in microvessel endothelium of human brain. NeuroReport 13:2059-2063 (2002).
10. W. Zhang, J. Mojsilovic-Petrovic, M. F. Andrade, H. Zhang, M. Ball, and D. B. Stanimirovic. The expression and functional characterization of ABCG2 in brain endothelial cells and vessels. FASEB J. 17:2085-2087 (2003).
11. Y. J. Lee, H. Kusuhara, J. W. Jonker, A. H. Schinkel, and Y. Sugiyama. Investigation of efflux transport of dehydroepiandrosterone sulfate and mitoxantrone at the mouse blood-brain barrier: A minor role of breast cancer resistance protein. J. Pharmacol. Exp. Ther. 312:44-52 (2005).
12. A. E. van Herwaarden, J. W. Jonker, E. Wagenaar, R. F. Brinkhuis, J. H. Schellens, J. H. Beijnen, and A. H. Schinkel. The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine. Cancer Res. 63:6447-6452 (2003).
13. S. Cisternino, C. Mercier, F. Bourasset, F. Roux, and J. M. Scherrmann. Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier. Cancer Res. 64:3296-3301 (2004).
14. P. Breedveld, D. Pluim, G. Cipriani, P. Wielinga, O. van Tellingen, A. H. Schinkel, and J. H. M. Schellens. The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (gleevec): Implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients. Cancer Res. 65:2577-2582 (2005).
15. I. Becker, K. F. Becker, R. Meyermann, and V. Hollt. The multidrug-resistance gene MDR1 is expressed in human glial tumors. Acta Neuropathol. (Berl). 82:516-519 (1991).
16. H. A. Volk and W. Loscher. Multidrug resistance in epilepsy: Rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures. Brain 128:1358-1368 (2005).
17. A. Prat, K. Biernacki, B. Becher, and J. P. Antel. B7 expression and antigen presentation by human brain endothelial cells: Requirement for proinflammatory cytokines. J. Neuropathol. Exp. Neurol. 59:129-136 (2000).
18. F. Roux, O. Durieu-Trautmann, N. Chaverot, M. Claire, P. Mailly, J. M. Bourre, A. D. Strosberg, and P.-O. Couraud. Regulation of gamma-glutamyl transpeptidase and alkaline phosphatase activities in immortalized rat brain microvessel endothelial cells. J. Cell. Physiol. 159:101-113 (1994).
19. R. Bendayan, G. Lee, and M. Bendayan. Functional expression and localization of P-glycoprotein at the blood-brain barrier. Microsc. Res. Tech. 57:365-380 (2002).
20. P. T. Ronaldson, M. Bendayan, D. Gingras, M. Piquette-Miller, and R. Bendayan. Cellular localization and functional expression of P-glycoprotein in rat astrocyte cultures. J. Neurochem. 89:788-800 (2004).
21. G. Lee, L. Schlichter, M. Bendayan, and R. Bendayan. Functional expression of P-glycoprotein in rat brain microglia. J. Pharmacol. Exp. Ther. 299:204-212 (2001).
22. R. W. Robey, Y. Honjo, A. van de Laar, K. Miyake, J. T. Regis, T. Litman, and S. E. Bates. A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2). Biochim. Biophys. Acta 1512:171-182 (2001).
23. R. W. Robey, K. Steadman, O. Polgar, and S. E. Bates. ABCG2-mediated transport of photosensitizers: Potential impact on photodynamic therapy. Cancer Biol. Ther. 4:187-194 (2005).
24. H. Minderman, A. Suvannasankha, K. L. O'Loughlin, G. L. Scheffer, R. J. Scheper, R. W. Robey, and M. R. Maer. Flow cytometric analysis of breast cancer resistance protein expression and function. Cytometry 48:59-65 (2002).
25. T. Litman, M. Brangi, E. Hudson, P. Fetsch, A. Abati, D. D. Ross, K. Miyake, J. H. Resau, and S. E. Bates. The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2). J. Cell Sci. 113:2011-2021 (2000).
26. A. Gupta, Y. Zhang, J. D. Unadkat, and Q. Mao. HIV protease inhibitors are inhibitors but not substrates of the human breast cancer resistance protein (BCRP/ABCG2). J. Pharmacol. Exp. Ther. 310:334-341 (2004).
27. Y. Honjo, C. A. Hrycyna, Q. W. Yan, W. Y. Medina-Perez, R. W. Robey, A. van de Laar, T. Litman, M. Dean, and S. E. Bates. Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells. Cancer Res. 61:6635-6639 (2001).
28. A. Regina, A. Koman, M. Piciotti, B. El Hafny, M. S. Center, R. Bergmann, P.-O. Couraud, and F. Roux. Mrp1 multidrug resistance-associated protein and P-glycoprotein expression in rat brain microvessel endothelial cells. J. Neurochem. 71:705-715 (1998).
29. S. Dallas, L. Schlichter, and R. Bendayan. Multidrug resistance protein (MRP) 4- and MRP 5-mediated efflux of 9-(2-phosphonylmethoxyethyl)adenine by microglia. J. Pharmacol. Exp. Ther. 309:1221-1229 (2004).
30. A. van Loevezijn, J. D. Allen, A. H. Schinkel, and G. J. Koomen. Inhibition of BCRP-mediated drug efflux by fumitremorgin-type indolyl diketopiperazines. Bioorg. Med. Chem. Lett. 11:29-32 (2001).
31. R. W. Robey, K. Steadman, O. Polgar, K. Morisaki, M. Blayney, P. Mistry, and S. E. Bates. Pheophorbide a is a specific probe for ABCG2 function and inhibition. Cancer Res. 64:1242-1246 (2004).
32. J. W. Jonker, M. Buitelaar, E. Wagenaar, M. A. Van Der Valk, G. L. Scheffer, R. J. Scheper, T. Plosch, F. Kuiper, R. P. J Oude Elferink, H. Rosing, J. H. Beijnen, and A. H. Schinkel. The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc. Natl. Acad. Sci. USA 99:15649-15654 (2002).
33. E. Aronica, J. A. Gorter, S. Redeker, E. A. van Vliet, M. Ramkema, G. L. Scheffer, R. J. Scheper, P. Van Der Valk, S. Leenstra, J. C. Baayen, W. G. M. Spliet, and D. Troost. Localization of breast cancer resistance protein (BCRP) in microvessel endothelium of human control and epileptic brain. Epilepsia 46:849-857 (2005).
34. E. Rocchi, A. Khodjakov, E. L. Volk, C. H. Yang, T. Litman, S. E. Bates, and E. Schneider. The product of the ABC half-transporter gene ABCG2 (BCRP/MXR/ABCP) is expressed in the plasma membrane. Biochem. Biophys. Res. Commun. 271:42-46 (2000).
35. X. Decleves, A. Regina, J. L. Laplanche, F. Roux, B. Boval, J. M. Launay, and J. M. Scherrmann. Functional expression of P-glycoprotein and multidrug resistance-associated protein (Mrp1) in primary cultures of rat astrocytes. J. Neurosci. Res. 60:594-601 (2000).
36. S. Dallas, X. Zhu, S. Baruchel, L. Schlichter, and R. Bendayan. Functional expression of the multidrug resistance protein 1 in microglia. J. Pharmacol. Exp. Ther. 307:282-290 (2003).
37. C. Ozvegy, A. Varadi, and B. Sarkadi. Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter. modulation of substrate specificity by a point mutation. J. Biol. Chem. 277:47980-47990 (2002).
38. B. Bauer, A. M. Hartz, G. Fricker, and D. S. Miller. Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood-brain barrier. Mol. Pharmacol. 66:413-419 (2004).
39. R. Bendayan, P. T. Ronaldson, D. Gingras, and M. Bendayan. In Situ localization of P-glycoprotein (ABCB1) in human and rat brain. J. Histochem. and Cytochem. 54:1159-1167 (2006).